Infectious Diseases

August 15, 2022
ROCHESTER, Minn. — Mayo Clinic researchers say the monoclonal antibody bebtelovimab, already authorized by the Food and Drug Administration for emergency use on the omicron[...]

August 25, 2016

August 18, 2016

August 16, 2016

August 8, 2016

August 4, 2016

August 3, 2016

August 3, 2016

July 25, 2016

July 22, 2016

July 22, 2016

July 7, 2016
Explore more topics
Sign up

Mayo Clinic Connect
An online patient support community